Antibodies specifically reactive with a tumor necrosis factor related ligand
US7087725B2 · kind B2 · utility
12Cited by
2References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 29, 2004 |
| Grant date | Aug 8, 2006 |
| Priority date | — |
| Expiry date | Feb 2, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2799/026
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.